Cetuximab prolongs survival in patients with locoregionally advanced squamous cell carcinoma of head and neck: A phase III study of high dose radiation therapy with or without cetuximab.
暂无分享,去创建一个
Christopher U. Jones | K. Ang | C. Jones | J. Baselga | P. Harari | D. Raben | R. Cohen | J. Giralt | M. Kies | J. Bonner | N. Azarnia | J. Baselga